Surprisingly, overexpression of FAM83D, but not AFP, was evident in 25.23% (55 of 218) of the HCC specimens (Figure 1E), suggesting that FAM83D may be considered to be a novel candidate biomarker for the pathogenesis of HCC. Here, AFP is linked to hepatocellular carcinoma.